T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
20 sept. 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™)
19 sept. 2024 08h00 HE
|
Humacyte, Inc
- New U.S. patent covers the design and composition of the BVP - - Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a...
SKB264 Innovative Cancer Antibody Drug Conjugate Clinical Trials Efficacy Insight
19 sept. 2024 07h34 HE
|
KuicK Research
Delhi, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SKB264, also known as MK-2870, is an innovative antibody-drug conjugate (ADC) targeting TROP2, currently being developed by Kelun Biotech in partnership...
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
19 sept. 2024 07h00 HE
|
Tonix Pharmaceuticals Holding Corp.
New patent expected to expire in 2030 Tosymra® (sumatriptan nasal spray) 10mg is indicated and marketed for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE)...
U.S. grants Vidac Pharma patent offering broad protection of mode of action underlying its oncology drug candidates
19 sept. 2024 01h00 HE
|
Vidac Pharma Holding PLC
London (UK), September 19 2024 – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class...
VoIP-Pal Files Motion for Reconsideration in the Mobile Gateway Patent Cases
17 sept. 2024 08h00 HE
|
Voip-Pal.Com Inc.
VoIP-Pal files a motion for reconsideraton in Mobile Gateway cases against Verizon andT-Mobile
ImmuneSensor Therapeutics Granted New U.S. Patent for its Oral cGAS Inhibitors
17 sept. 2024 08h00 HE
|
ImmuneSensor Therapeutics
Composition and methods patent granted claims covering compounds for treating broad range of inflammatory and autoimmune diseases and built on foundational intellectual property for the discovery of...
Bispecific Antibody Drug Conjugates Clinical Trials Insight
17 sept. 2024 07h14 HE
|
KuicK Research
Delhi, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The global market for bispecific antibody-drug conjugates (BsADCs) has experienced remarkable expansion, attributed to their revolutionary capabilities in...
Biotalys Granted Patents for EVOCA in Both Europe and the United States
17 sept. 2024 01h00 HE
|
Biotalys NV
Ghent, Belgium, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Biotalys (Euronext BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today...
U.S. Grants Gevo a Patent for Breakthrough Ethanol-to-Olefin Process
16 sept. 2024 08h55 HE
|
Gevo, Inc.
ENGLEWOOD, Colo., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) is proud to announce the U.S. Patent and Trademark Office has granted to Gevo, a patent for its ethanol to olefins...